Literature DB >> 20438907

Histopathologic improvement in biliary cirrhosis after definitive surgery for choledochal cyst.

Tetsuya Ishimaru1, Yoshihiro Kitano, Hiroo Uchida, Hiroshi Kawashima, Chikashi Gotoh, Kaori Satoh, Mariko Yoshida, Hiroshi Kishimoto, Tadashi Iwanaka.   

Abstract

Choledochal cyst causes liver fibrosis, the extent of which varies with each case. Liver damage seldom progresses to cirrhosis, but when it does, it is generally irreversible. We report an infantile case of liver cirrhosis associated with choledochal cyst in which complete clinical resolution was achieved by surgery. Pancytopenia caused by splenomegaly, massive ascites, hypoalbuminemia, and coagulation abnormality that were observed during the early postoperative period had disappeared within 4 months after surgery. Needle liver biopsy performed at 1 year after surgery revealed marked improvement in liver fibrosis. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20438907     DOI: 10.1016/j.jpedsurg.2010.01.030

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  4 in total

Review 1.  Laparoscopic management of choledochal cysts: is a keyhole view missing the big picture?

Authors:  Mark D Stringer
Journal:  Pediatr Surg Int       Date:  2017-04-19       Impact factor: 1.827

Review 2.  Role of laparoscopy in treatment of choledochal cysts in children.

Authors:  Mei Diao; Long Li; Wei Cheng
Journal:  Pediatr Surg Int       Date:  2013-01-31       Impact factor: 1.827

3.  Choledochal cysts in infants and children: experiences over a 20-year period at a single institution.

Authors:  Min-Hsuan Hung; Lung-Huang Lin; Der-Fang Chen; Ching-Shui Huang
Journal:  Eur J Pediatr       Date:  2011-02-25       Impact factor: 3.183

4.  Clinical analysis of liver fibrosis in choledochal cyst.

Authors:  Shigehisa Fumino; Koji Higuchi; Shigeyoshi Aoi; Taizo Furukawa; Osamu Kimura; Tatsuro Tajiri
Journal:  Pediatr Surg Int       Date:  2013-11       Impact factor: 1.827

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.